Ancillary fish analysis for 1p and 19q status: Preliminary observations in 287 gliomas and oligodendroglioma mimics

被引:103
作者
Perry, A
Fuller, CE
Banerjee, R
Brat, DJ
Scheithauer, BW
机构
[1] Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63110 USA
[2] Emory Univ Hosp, Div Neuropathol, Atlanta, GA 30322 USA
[3] Mayo Clin, Div Neuropathol, Rochester, MN USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2003年 / 8卷
关键词
astrocytoma; brain tumors; chromosome; 1; 19; dysembryoplastic neuroepithelial tumor; genetics; in situ hybridization; loss of heterozygosity; neurocytoma; oligodendroglioma; prognosis; review;
D O I
10.2741/896
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deletions of chromosomes 1p and 19q are associated with chemosensitivity and enhanced survival in oligodendrogliomas. Therefore, we have utilized FISH analysis as an ancillary tool for diffuse gliomas with suspected oligodendroglial features. To date, 246 gliomas have been analyzed in 131 male and 93 female patients, including 109 oligodendrogliomas (O), 109 mixed oligoastrocytomas / equivocal gliomas (MOA), and 28 astrocytomas (A). To address specificity, we also analyzed 41 oligodendroglioma mimics, including 12 central and 12 extraventricular neurocytomas (EVN), 12 dysembryoplastic neuroepithelial tumors, and 5 clear cell ependymomas. Aside from 2 EVNs, no mimics demonstrated codeletion. Three patterns were associated with glioma cell type (O vs. MOA/A): -1p/19q, -19q alone, and polysomies. Long-term survivals of >5-years (N=47) and >10-years (N=16) were associated with 1p/19q codeletion in 60% and 75% respectively, whereas solitary 19q deletion accounted for 11% and 6% respectively. Survivals <2-years (N=10) were associated with lack of deletions in 70%. A few older patients with high-grade, "genetically favorable" tumors did poorly, whereas prolonged survival was observed in several low-grade glioma patients despite a lack of the "genetically favorable" pattern. Our data suggests that: 1) FISH-detectable 1p/19q codeletion is relatively specific for oligodendrogliomas with long survival, 2) solitary 19q deletion may also portend a favorable prognosis in a smaller subset, and 3) combined clinicopathologic and genetic assessment likely provides a more accurate means of patient stratification than either one alone.
引用
收藏
页码:A1 / A9
页数:9
相关论文
共 52 条
  • [11] 2-V
  • [12] Small cell architecture - A histological equivalent of EGFR amplification in glioblastoma multiforme?
    Burger, PC
    Pearl, DK
    Aldape, K
    Yates, AJ
    Scheithauer, BW
    Passe, SM
    Jenkins, RB
    James, CD
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (11) : 1099 - 1104
  • [13] Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: Diagnostic and prognostic implications
    Cai, DX
    Banerjee, R
    Scheithauer, BW
    Lohse, CM
    Kleinschmidt-DeMasters, BK
    Perry, A
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (06) : 628 - 636
  • [14] CHEMOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIOMA
    CAIRNCROSS, G
    MACDONALD, D
    LUDWIN, S
    LEE, D
    CASCINO, T
    BUCKNER, J
    FULTON, D
    DROPCHO, E
    STEWART, D
    SCHOLD, C
    WAINMAN, N
    EISENHAUER, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) : 2013 - 2021
  • [15] Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
    Cairncross, JG
    Ueki, K
    Zlatescu, MC
    Lisle, DK
    Finkelstein, DM
    Hammond, RR
    Silver, JS
    Stark, PC
    Macdonald, DR
    Ino, Y
    Ramsay, DA
    Louis, DN
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) : 1473 - 1479
  • [16] SUCCESSFUL CHEMOTHERAPY FOR RECURRENT MALIGNANT OLIGODENDROGLIOMA
    CAIRNCROSS, JG
    MACDONALD, DR
    [J]. ANNALS OF NEUROLOGY, 1988, 23 (04) : 360 - 364
  • [17] Investigation of genetic alterations associated with development and adverse outcome in patients with astrocytic tumor
    Cianciulli, AM
    Morace, E
    Coletta, AM
    Occhipinti, E
    Gandolfo, GM
    Leonardo, G
    Carapella, CM
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2000, 48 (02) : 95 - 101
  • [18] Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO
  • [19] 2-W
  • [20] Oligodendrogliomas .1. Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases
    DaumasDuport, C
    Varlet, P
    Tucker, ML
    Beuvon, F
    Cervera, P
    Chodkiewicz, JP
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1997, 34 (01) : 37 - 59